Búsqueda | Biblioteca Virtual en Salud Fronteriza

1.

DNA damage promotes HLA class I presentation by stimulating a pioneer round of translation-associated antigen production.

Uchihara, Yuki; Permata, Tiara Bunga Mayang; Sato, Hiro; Kawabata-Iwakawa, Reika; Katada, Sayako; Gu, Wenchao; Kakoti, Sangeeta; Yamauchi, Motohiro; Kato, Reona; Gondhowiardjo, Soehartati; Hosen, Naoki; Yasuhara, Takaaki; Shibata, Atsushi.

Mol Cell ; 82(14): 2557-2570.e7, 2022 07 21.

Artículo en Inglés | MEDLINE | ID: mdl-35594857

2.

The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients.

Shimazu, Yutaka; Kanda, Junya; Onda, Yoshiyuki; Fuchida, Shin-Ichi; Ohta, Kensuke; Shimura, Yuji; Kosugi, Satoru; Yamamura, Ryosuke; Matsuda, Mitsuhiro; Hanamoto, Hitoshi; Adachi, Yoko; Anzai, Naoyuki; Hotta, Masaaki; Fukushima, Kentaro; Yagi, Hideo; Yoshihara, Satoshi; Tanaka, Yasuhiro; Takakuwa, Teruhito; Tanaka, Hirokazu; Shibayama, Hirohiko; Uoshima, Nobuhiko; Hosen, Naoki; Ito, Tomoki; Shimazaki, Chihiro; Matsumura, Itaru; Kuroda, Junya; Takaori-Kondo, Akifumi; Hino, Masayuki.

Cancer Immunol Immunother ; 73(7): 135, 2024 May 17.

Artículo en Inglés | MEDLINE | ID: mdl-38758239

3.

Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study.

Nakamura, Naokazu; Arima, Nobuyoshi; Takakuwa, Teruhito; Yoshioka, Satoshi; Imada, Kazunori; Fukushima, Kentaro; Hotta, Masaaki; Fuchida, Shin-Ichi; Kanda, Junya; Uoshima, Nobuhiko; Shimura, Yuji; Tanaka, Hirokazu; Ohta, Kensuke; Kosugi, Satoru; Yagi, Hideo; Yoshihara, Satoshi; Yamamura, Ryosuke; Adachi, Yoko; Hanamoto, Hitoshi; Shibayama, Hirohiko; Hosen, Naoki; Ito, Tomoki; Shimazaki, Chihiro; Takaori-Kondo, Akifumi; Kuroda, Junya; Matsumura, Itaru; Hino, Masayuki.

Ann Hematol ; 2024 Mar 16.

Artículo en Inglés | MEDLINE | ID: mdl-38492020

4.

Special AT-Rich Sequence-Binding Protein 1 Supports Survival and Maturation of Naive B Cells Stimulated by B Cell Receptors.

Ozawa, Takayuki; Fujii, Kentaro; Sudo, Takao; Doi, Yukiko; Nakai, Ritsuko; Shingai, Yasuhiro; Ueda, Tomoaki; Baba, Yoshihiro; Hosen, Naoki; Yokota, Takafumi.

J Immunol ; 208(8): 1937-1946, 2022 04 15.

Artículo en Inglés | MEDLINE | ID: mdl-35379742

5.

[Sequential therapy with inotuzumab ozogamicin followed by CAR T-cell therapy for Philadelphia chromosome-negative acute lymphoblastic leukemia].

Mizutani, Yo; Kusakabe, Shinsuke; Fukushima, Kentaro; Murakami, Hiraku; Hamada, Masataka; Hasegawa, Chihiro; Mizuta, Emiko; Yamaguchi, Yuta; Nakai, Ritsuko; Kurashige, Ryumei; Hino, Akihisa; Ueda, Tomoaki; Fujita, Jiro; Miyamura, Takako; Hosen, Naoki.

Rinsho Ketsueki ; 65(2): 78-83, 2024.

Artículo en Japonés | MEDLINE | ID: mdl-38448002

6.

XCR1⁺ conventional dendritic cell-induced CD4⁺ T helper 1 cell activation exacerbates cardiac remodeling after ischemic myocardial injury.

Inui, Hiroyasu; Nishida, Makoto; Ichii, Michiko; Nakaoka, Hajime; Asaji, Masumi; Ide, Seiko; Saito, Shigeyoshi; Saga, Ayami; Omatsu, Takashi; Tanaka, Katsunao; Kanno, Kotaro; Chang, Jiuyang; Zhu, Yinghong; Okada, Takeshi; Okuzaki, Daisuke; Matsui, Takahiro; Ohama, Tohru; Koseki, Masahiro; Morii, Eiichi; Hosen, Naoki; Yamashita, Shizuya; Sakata, Yasushi.

J Mol Cell Cardiol ; 176: 68-83, 2023 03.

Artículo en Inglés | MEDLINE | ID: mdl-36739942

7.

Prolonged gut microbial alterations in post-transplant survivors of allogeneic haematopoietic stem cell transplantation.

Hino, Akihisa; Fukushima, Kentaro; Kusakabe, Shinsuke; Ueda, Tomoaki; Sudo, Takao; Fujita, Jiro; Motooka, Daisuke; Takeda, Aya K; Shinozaki, Natsuko O; Watanabe, Satoshi; Yokota, Takafumi; Shibayama, Hirohiko; Nakamura, Shota; Hosen, Naoki.

Br J Haematol ; 201(4): 725-737, 2023 05.

Artículo en Inglés | MEDLINE | ID: mdl-36468273

8.

[Identifying and targeting multiple myeloma-specific antigens resulting from post-translational protein modifications by CAR-T cell therapies].

Hosen, Naoki.

Rinsho Ketsueki ; 64(5): 427-431, 2023.

Artículo en Japonés | MEDLINE | ID: mdl-37271535

9.

[Acquired hemophilia A following BNT162b2 mRNA COVID-19 vaccination].

Senda, Ayami; Saito, Hideaki; Kusakabe, Shinsuke; Yoshida, Koki; Shibata, Kumi; Kida, Shuhei; Toda, Jun; Hino, Akihisa; Ueda, Tomoaki; Fujita, Jiro; Fukushima, Kentaro; Yokota, Takafumi; Kashiwagi, Hirokazu; Hosen, Naoki.

Rinsho Ketsueki ; 64(1): 35-41, 2023.

Artículo en Japonés | MEDLINE | ID: mdl-36775305

10.

Impaired B cell terminal differentiation in B cell-specific knockout mice of cell death-defying factor anamorsin.

Hamanaka, Yuri; Tanimura, Akira; Yokota, Takafumi; Ezoe, Sachiko; Ichii, Michiko; Nagate, Yasuhiro; Oritani, Kenji; Kanakura, Yuzuru; Hosen, Naoki; Shibayama, Hirohiko.

Biochem Biophys Res Commun ; 603: 1-6, 2022 05 07.

Artículo en Inglés | MEDLINE | ID: mdl-35259639

11.

Autonomous TGFß signaling induces phenotypic variation in human acute myeloid leukemia.

Shingai, Yasuhiro; Yokota, Takafumi; Okuzaki, Daisuke; Sudo, Takao; Ishibashi, Tomohiko; Doi, Yukiko; Ueda, Tomoaki; Ozawa, Takayuki; Nakai, Ritsuko; Tanimura, Akira; Ichii, Michiko; Shibayama, Hirohiko; Kanakura, Yuzuru; Hosen, Naoki.

Stem Cells ; 39(6): 723-736, 2021 06.

Artículo en Inglés | MEDLINE | ID: mdl-33539590

12.

Passive immune basophil activation test for the identification of allergic episodes from various adverse events elicited by haematopoietic cell transplantation: A pilot study.

Yasui, Kazuta; Enami, Terukazu; Okamura-Shiki, Ikue; Ueda, Tomoaki; Fukushima, Kentaro; Matsuyama, Nobuki; Kimura, Takafumi; Takanashi, Minoko; Hosen, Naoki; Ikeda, Takashi; Takihara, Yoshihiro; Hirayama, Fumiya.

Vox Sang ; 117(1): 119-127, 2022 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-34081781

13.

Graft-versus-host disease develops in mice transplanted with lymphocyte-depleted bone marrow cells from signal-transducing adaptor protein-2 transgenic mice.

Saito, Hideaki; Ichii, Michiko; Toda, Jun; Kitai, Yuichi; Muromoto, Ryuta; Kashiwakura, Jun-Ichi; Saitoh, Kodai; Tanimura, Akira; Yokota, Takafumi; Shibayama, Hirohiko; Matsuda, Tadashi; Oritani, Kenji; Kanakura, Yuzuru; Hosen, Naoki.

Biochem Biophys Res Commun ; 537: 118-124, 2021 01 22.

Artículo en Inglés | MEDLINE | ID: mdl-33388414

14.

Identification of two distinct populations of WT1-specific cytotoxic T lymphocytes in co-vaccination of WT1 killer and helper peptides.

Fujiki, Fumihiro; Tsuboi, Akihiro; Morimoto, Soyoko; Hashimoto, Naoya; Inatome, Miki; Nakajima, Hiroko; Nakata, Jun; Nishida, Sumiyuki; Hasegawa, Kana; Hosen, Naoki; Oka, Yoshihiro; Oji, Yusuke; Sogo, Shinji; Sugiyama, Haruo.

Cancer Immunol Immunother ; 70(1): 253-263, 2021 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-32696072

15.

Identification of mouse helper epitopes for WT1-specific CD4⁺ T cells.

Nakajima, Hiroko; Nakata, Jun; Imafuku, Kanako; Hayashibara, Hiromu; Isokawa, Kazuki; Udaka, Keiko; Fujiki, Fumihiro; Morimoto, Soyoko; Hasegawa, Kana; Hosen, Naoki; Hashii, Yoshiko; Nishida, Sumiyuki; Tsuboi, Akihiro; Oka, Yoshihiro; Oji, Yusuke; Sogo, Shinji; Sugiyama, Haruo.

Cancer Immunol Immunother ; 70(11): 3323-3335, 2021 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-34272593

16.

[Chimeric antigen receptor T-cell therapy for multiple myeloma].

Hosen, Naoki.

Rinsho Ketsueki ; 62(6): 619-623, 2021.

Artículo en Japonés | MEDLINE | ID: mdl-34219089

17.

[Multiple myeloma and integrins].

Hosen, Naoki.

Rinsho Ketsueki ; 61(7): 827-831, 2020.

Artículo en Japonés | MEDLINE | ID: mdl-32759571

18.

A phase I clinical study of a cocktail vaccine of Wilms' tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma.

Tsuboi, Akihiro; Hashimoto, Naoya; Fujiki, Fumihiro; Morimoto, Soyoko; Kagawa, Naoki; Nakajima, Hiroko; Hosen, Naoki; Nishida, Sumiyuki; Nakata, Jun; Morita, Satoshi; Sakamoto, Junichi; Oji, Yusuke; Oka, Yoshihiro; Sugiyama, Haruo.

Cancer Immunol Immunother ; 68(2): 331-340, 2019 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-30430205

19.

WT1 peptide-based immunotherapy for advanced thymic epithelial malignancies.

Oji, Yusuke; Inoue, Masayoshi; Takeda, Yoshito; Hosen, Naoki; Shintani, Yasushi; Kawakami, Manabu; Harada, Takuya; Murakami, Yui; Iwai, Miki; Fukuda, Mari; Nishida, Sumiyuki; Nakata, Jun; Nakae, Yoshiki; Takashima, Satoshi; Shirakata, Toshiaki; Nakajima, Hiroko; Hasegawa, Kana; Kida, Hiroshi; Kijima, Takashi; Morimoto, Soyoko; Fujiki, Fumihiro; Tsuboi, Akihiro; Morii, Eiichi; Morita, Satoshi; Sakamoto, Junichi; Kumanogoh, Atsushi; Oka, Yoshihiro; Okumura, Meinoshin; Sugiyama, Haruo.

Int J Cancer ; 142(11): 2375-2382, 2018 06 01.

Artículo en Inglés | MEDLINE | ID: mdl-29322496

20.

Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension.

Hashimoto-Kataoka, Takahiro; Hosen, Naoki; Sonobe, Takashi; Arita, Yoh; Yasui, Taku; Masaki, Takeshi; Minami, Masato; Inagaki, Tadakatsu; Miyagawa, Shigeru; Sawa, Yoshiki; Murakami, Masaaki; Kumanogoh, Atsushi; Yamauchi-Takihara, Keiko; Okumura, Meinoshin; Kishimoto, Tadamitsu; Komuro, Issei; Shirai, Mikiyasu; Sakata, Yasushi; Nakaoka, Yoshikazu.

Proc Natl Acad Sci U S A ; 112(20): E2677-86, 2015 May 19.

Artículo en Inglés | MEDLINE | ID: mdl-25941359

Biblioteca Virtual en Salud Fronteriza

México - Estados Unidos

Su selección (0)

Formato de exportación:

Exportar:

DNA damage promotes HLA class I presentation by stimulating a pioneer round of translation-associated antigen production.

The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients.

Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study.

Special AT-Rich Sequence-Binding Protein 1 Supports Survival and Maturation of Naive B Cells Stimulated by B Cell Receptors.

[Sequential therapy with inotuzumab ozogamicin followed by CAR T-cell therapy for Philadelphia chromosome-negative acute lymphoblastic leukemia].

XCR1⁺ conventional dendritic cell-induced CD4⁺ T helper 1 cell activation exacerbates cardiac remodeling after ischemic myocardial injury.

Prolonged gut microbial alterations in post-transplant survivors of allogeneic haematopoietic stem cell transplantation.

[Identifying and targeting multiple myeloma-specific antigens resulting from post-translational protein modifications by CAR-T cell therapies].

[Acquired hemophilia A following BNT162b2 mRNA COVID-19 vaccination].

Impaired B cell terminal differentiation in B cell-specific knockout mice of cell death-defying factor anamorsin.

Autonomous TGFß signaling induces phenotypic variation in human acute myeloid leukemia.

Passive immune basophil activation test for the identification of allergic episodes from various adverse events elicited by haematopoietic cell transplantation: A pilot study.

Graft-versus-host disease develops in mice transplanted with lymphocyte-depleted bone marrow cells from signal-transducing adaptor protein-2 transgenic mice.

Identification of two distinct populations of WT1-specific cytotoxic T lymphocytes in co-vaccination of WT1 killer and helper peptides.

Identification of mouse helper epitopes for WT1-specific CD4⁺ T cells.

[Chimeric antigen receptor T-cell therapy for multiple myeloma].

[Multiple myeloma and integrins].

A phase I clinical study of a cocktail vaccine of Wilms' tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma.

WT1 peptide-based immunotherapy for advanced thymic epithelial malignancies.

Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension.